Craven, Gregory B. https://orcid.org/0000-0003-3414-8348
Chu, Hang
Sun, Jessica D.
Carelli, Jordan D.
Coyne, Brittany
Chen, Hao https://orcid.org/0009-0006-0920-8782
Chen, Ying
Ma, Xiaolei https://orcid.org/0000-0002-5307-827X
Das, Subhamoy
Kong, Wayne
Zajdlik, Adam D.
Yang, Kin S.
Reisberg, Solomon H.
Thompson, Peter A.
Lipford, J. Russell
Taunton, Jack https://orcid.org/0000-0002-9627-5898
Article History
Received: 17 November 2023
Accepted: 8 October 2024
First Online: 6 November 2024
Competing interests
: H. Chu., J.D.S., J.D.C., B.C., X.M., S.D., W.K., A.D.Z., K.S.Y., S.H.R., P.A.T. and J.R.L. are current or former employees of Terremoto Biosciences. J.T. is a cofounder of Kezar Life Sciences and Terremoto Biosciences and is a scientific advisor to Iambic Therapeutics. J.T., G.B.C., S.H.R., K.S.Y., H.C., J.D.C. and P.A.T. are inventors on a patent application filed by the University of California and Terremoto Biosciences (WO2023168291A1). The remaining authors declare no competing interests.